SHS Capital and ING Corporate Investments Acquire Majority Stake in CAM Bioceramics
July 7, 2023
German healthcare specialist investor SHS Capital, together with ING Corporate Investments and several co-investors, acquired a majority stake in CAM Bioceramics B.V., a Leiden-based contract development and manufacturing organization (CDMO) for orthobiologic calcium phosphate solutions. Existing owners rolled over a significant stake and management remains in place; the transaction aims to strengthen the business and accelerate investment in people, capabilities and customer partnerships to drive growth.
- Buyers
- SHS Capital, ING Corporate Investments, Several Co-Investors
- Targets
- CAM Bioceramics B.V.
- Sellers
- Existing shareholders (rolled over significant stake)
- Industry
- Medical Devices
- Location
- South Holland, Netherlands
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SHS Capital Invests €18M in MESI Medical
June 22, 2023
Medical Devices
Tübingen-based healthcare investor SHS (SHS Gesellschaft für Beteiligungsmanagement mbH) has invested €18 million in MESI, a Slovenian medtech company that develops the MESI mTABLET digital diagnostic platform. The growth capital will be used to expand MESI’s sales organization and product portfolio — including AI-powered predictive applications — to accelerate adoption across primary care, assisted care and other healthcare settings.
-
SHS Invests in Blue Ocean Spine GmbH
January 12, 2021
Medical Devices
SHS Gesellschaft für Beteiligungsmanagement (SHS) is the lead investor in Blue Ocean Spine GmbH, a Tuttlingen, Germany-based developer of functional spinal implants that uses additive manufacturing. The investment will support product development, manufacturing scale-up and regulatory activities as Blue Ocean Spine advances next-generation expandable and anchor-equipped cage implants and targets future U.S. FDA approval.
-
SHS Acquires 24.9% Minority Stake in Blazejewski MEDI-TECH GmbH
February 27, 2020
Medical Devices
Tuebingen-based investor SHS Gesellschaft fuer Beteiligungsmanagement mbH has taken a 24.9% minority stake in Sexau-based endoscope manufacturer Blazejewski MEDI-TECH GmbH. The investment is intended to provide growth capital, sector expertise and regulatory support to accelerate internationalization and product development (including 3D endoscopy) for the 70-employee medical device firm.
-
Silver Investment Partners Acquires Stake in Crystal GmbH from SHS
June 22, 2021
Medical Devices
Silver Investment Partners (SIP) has acquired the stake in Berlin-based Crystal GmbH from healthcare investor SHS. The investor transition will support Crystal's planned growth — development of new products, expanded production capacity and increased international sales — while SHS completes its exit.
-
SHS Invests in Develco Pharma
December 17, 2020
Pharmaceuticals
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is making a minority growth investment from its SHS V fund in Swiss-German specialty drug company Develco Pharma. Develco, headquartered in Pratteln, Switzerland with ~125 employees and production in Schopfheim, Germany, develops and manufactures orally administered prolonged-release medicines and will use the investment to broaden its pipeline and expand capabilities.
-
SHS Capital and LPs Invest ~€10M in Develco Pharma
October 7, 2024
Pharmaceuticals
SHS Capital, together with its limited partners and other existing shareholders, is investing approximately €10 million in Develco Pharma to expand manufacturing capacity and accelerate product development in response to exceptionally strong demand. Develco, a specialty pharma developer and manufacturer of modified-release formulations headquartered in Pratteln (DACH region), has been backed by SHS since 2020 and reports an order book exceeding 12 months of revenue.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.